GSK posts strong growth thanks to Haleon spin-off and vaccines push

GSK beat market estimates in its fourth-quarter results and unveiled an upbeat forecast for 2024 and beyond on the acceleration of its vaccines and cancer drug pipeline.

Share This Post:

POPULAR POSTS
FOLLOW US
Like Us On Facebook
Follow Us On Twitter
Subscribe To Our Channel
TikTok
LIVE STREAM